Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the leading causes of cancer-related death worldwide. Advanced HCC displays strong resistance to chemotherapy, and traditional chemotherapy drugs do not achieve satisfactory therapeutic efficacy. Sorafenib is an oral k...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Fan-Hua, Ye, Qi-Fa, Miao, Xiong-Ying, Liu, Xi, Huang, Si-Qi, Xiong, Li, Wen, Yu, Zhang, Zi-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039945/
https://www.ncbi.nlm.nih.gov/pubmed/33859758
http://dx.doi.org/10.7150/thno.54822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039945/
https://www.ncbi.nlm.nih.gov/pubmed/33859758
http://dx.doi.org/10.7150/thno.54822

Ejemplares similares